Herbert Virgin Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Herbert Virgin is EVP, Research & CSO of Vir Biotechnology, Inc.. Currently has a direct ownership of 262,500 shares of VIR, which is worth approximately $1.76 Million. The most recent transaction as insider was on Jan 26, 2021, when has been sold 31,300 shares (Common Stock) at a price of $48.17 per share, resulting in proceeds of $1,507,721. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K
0% 3M change
0% 12M change
Total Value Held $1.76 Million

Herbert Virgin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2021
SELL
Open market or private sale
$1,507,721 $48.17 p/Share
31,300 Reduced 48.53%
33,200 Common Stock
Jan 26 2021
BUY
Exercise of conversion of derivative security
$47,889 $1.53 p/Share
31,300 Added 32.67%
64,500 Common Stock
Jan 15 2021
SELL
Open market or private sale
$400,140 $38.0 p/Share
10,530 Reduced 24.08%
33,200 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$16,111 $1.53 p/Share
10,530 Added 19.41%
43,730 Common Stock
Jan 12 2021
SELL
Open market or private sale
$111,715 $29.36 p/Share
3,805 Reduced 10.28%
33,200 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$5,822 $1.53 p/Share
3,805 Added 9.32%
37,005 Common Stock
Dec 24 2020
BUY
Exercise of conversion of derivative security
$14,535 $1.53 p/Share
9,500 Added 22.25%
33,200 Common Stock
Dec 22 2020
SELL
Open market or private sale
$118,678 $31.19 p/Share
3,805 Reduced 13.83%
23,700 Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$5,822 $1.53 p/Share
3,805 Added 12.15%
27,505 Common Stock
Dec 08 2020
SELL
Open market or private sale
$118,982 $31.27 p/Share
3,805 Reduced 13.83%
23,700 Common Stock
Dec 08 2020
BUY
Exercise of conversion of derivative security
$5,822 $1.53 p/Share
3,805 Added 12.15%
27,505 Common Stock
Nov 27 2020
SELL
Open market or private sale
$87,900 $30.0 p/Share
2,930 Reduced 11.0%
23,700 Common Stock
Nov 27 2020
BUY
Exercise of conversion of derivative security
$4,483 $1.53 p/Share
2,930 Added 9.91%
26,630 Common Stock
Nov 24 2020
SELL
Open market or private sale
$63,859 $27.29 p/Share
2,340 Reduced 8.99%
23,700 Common Stock
Nov 24 2020
BUY
Exercise of conversion of derivative security
$3,580 $1.53 p/Share
2,340 Added 8.25%
26,040 Common Stock
Nov 10 2020
SELL
Open market or private sale
$61,448 $26.26 p/Share
2,340 Reduced 8.99%
23,700 Common Stock
Nov 10 2020
BUY
Exercise of conversion of derivative security
$3,580 $1.53 p/Share
2,340 Added 8.25%
26,040 Common Stock
Oct 27 2020
SELL
Open market or private sale
$133,327 $35.04 p/Share
3,805 Reduced 13.83%
23,700 Common Stock
Oct 27 2020
BUY
Exercise of conversion of derivative security
$5,822 $1.53 p/Share
3,805 Added 12.15%
27,505 Common Stock
Oct 13 2020
SELL
Open market or private sale
$239,247 $43.03 p/Share
5,560 Reduced 19.0%
23,700 Common Stock
Oct 13 2020
BUY
Exercise of conversion of derivative security
$8,507 $1.53 p/Share
5,560 Added 15.97%
29,260 Common Stock
Sep 29 2020
SELL
Open market or private sale
$133,380 $38.0 p/Share
3,510 Reduced 12.9%
23,700 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$5,370 $1.53 p/Share
3,510 Added 11.43%
27,210 Common Stock
HV

Herbert Virgin

EVP, Research & CSO
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR